BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Prognosis
24 results:

  • 1. Down syndrome and leukemia: An insight into the disease biology and current treatment options.
    Barwe SP; Kolb EA; Gopalakrishnapillai A
    Blood Rev; 2024 Mar; 64():101154. PubMed ID: 38016838
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The paradox of Myeloid leukemia associated with Down syndrome.
    Gupte A; Al-Antary ET; Edwards H; Ravindranath Y; Ge Y; Taub JW
    Biochem Pharmacol; 2022 Jul; 201():115046. PubMed ID: 35483417
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hematological disorders in children with Down syndrome.
    Triarico S; Trombatore G; Capozza MA; Romano A; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
    Expert Rev Hematol; 2022 Feb; 15(2):127-135. PubMed ID: 35184659
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute Erythroleukemia.
    Liu W; Wu Z; Yu Y; Qiao C; Zhu H; Hong M; Zhu Y; Qian S; Chen S; Wu D; Li J; Jin H
    Oxid Med Cell Longev; 2022; 2022():5885342. PubMed ID: 35140839
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects.
    Ureshino H; Kurahashi Y; Watanabe T; Yamashita S; Kamachi K; Yamamoto Y; Fukuda-Kurahashi Y; Yoshida-Sakai N; Hattori N; Hayashi Y; Kawaguchi A; Tohyama K; Okada S; Harada H; Ushijima T; Kimura S
    Mol Cancer Ther; 2021 Aug; 20(8):1412-1421. PubMed ID: 34045225
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Analysis of Clinical Characteristics and prognosis in Children with Acute Megakaryoblastic leukemia without Down Syndrome].
    Lin SF; Guo SY; Liu S; Wang J; Huang K; Li Y; Fang JP; Zhou DH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):374-380. PubMed ID: 33812402
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Case of Congenital leukemia With MYB-gata1 Fusion Gene in a Female Patient.
    Ozono S; Yano S; Oishi S; Mitsuo M; Nakagawa S; Toki T; Terui K; Ito E
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e250-e252. PubMed ID: 33661169
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Modeling and targeting of erythroleukemia by hematopoietic genome editing.
    Iacobucci I; Qu C; Varotto E; Janke LJ; Yang X; Seth A; Shelat A; Friske JD; Fukano R; Yu J; Freeman BB; Kennedy JA; Sperling AS; Zheng R; Wang Y; Jogiraju H; Dickerson KM; Payne-Turner D; Morris SM; Hollis ES; Ghosn N; Haggard GE; Lindsley RC; Ebert BL; Mullighan CG
    Blood; 2021 Mar; 137(12):1628-1640. PubMed ID: 33512458
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Monitoring minimal residual disease in pediatric acute myeloid leukemia].
    Taga T
    Rinsho Ketsueki; 2020; 61(8):971-978. PubMed ID: 32908063
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia.
    De Marchi F; Araki M; Komatsu N
    Expert Rev Hematol; 2019 May; 12(5):285-293. PubMed ID: 30991862
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. microRNA-23a, -27a and -24 synergistically regulate JAK1/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia.
    Su R; Dong L; Zou D; Zhao H; Ren Y; Li F; Yi P; Li L; Zhu Y; Ma Y; Wang J; Wang F; Yu J
    Oncogene; 2016 Nov; 35(46):6001-6014. PubMed ID: 27086927
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The biology of pediatric acute megakaryoblastic leukemia.
    Gruber TA; Downing JR
    Blood; 2015 Aug; 126(8):943-9. PubMed ID: 26186939
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. prognosis and management of acute myeloid leukemia in patients with Down syndrome.
    Caldwell JT; Ge Y; Taub JW
    Expert Rev Hematol; 2014 Dec; 7(6):831-40. PubMed ID: 25231553
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
    Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
    J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.
    Kudo K; Hama A; Kojima S; Ishii R; Morimoto A; Bessho F; Sunami S; Kobayashi N; Kinoshita A; Okimoto Y; Tawa A; Tsukimoto I
    Int J Hematol; 2010 May; 91(4):630-5. PubMed ID: 20237876
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
    Tigay JH
    J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Relapsed acute myeloid leukemia with Down syndrome showing long disease-free survival after bone marrow transplantation].
    Daifu T; Kato I; Matubara H; Abe D; Uryu K; Tokumasu M; Umeda K; Watanabe K; Izawa K; Asai K; Nakahata T; Adachi S
    Rinsho Ketsueki; 2009 Feb; 50(2):73-7. PubMed ID: 19265297
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. gata1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
    Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
    Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.
    Ayala RM; Martínez-López J; Albízua E; Diez A; Gilsanz F
    Am J Hematol; 2009 Feb; 84(2):79-86. PubMed ID: 19097174
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.